Investigator Initiated Extended Clinical Trial (R01 Clinical Trial Required)

Funding Agency:
National Institutes of Health

This Funding Opportunity Announcement (FOA) invites applications for implementation of investigator-initiated clinical trials requiring an extended project period of 6 or 7 years. The trials can be any phase, must be hypothesis-driven, and related to the research mission of the participating IC. Consultation with IC staff is strongly encouraged prior to the submission of the clinical trial implementation application. This FOA is not intended for support of clinical trials that do not require an extended project period of 6 or 7 years.

Deadlines:

  • Letter of Intent Due Date(s): 30 days prior to the application due date

  • Application Due Date(s): May 15, 2023; Sep 13, 2023; Jan 16, 2024; May 13, 2024; Sep 13, 2024; Jan 13, 2025; May 13, 2025; Sep 15, 2025; Jan 13, 2026

  • AIDS Application Due Date(s): May 15, 2023; Sep 13, 2023; Jan 16, 2024; May 13, 2024; Sep 13, 2024; Jan 13, 2025; May 13, 2025; Sep 15, 2025; Jan 13, 2026

PAR-23-084 Expiration Date January 14, 2026

 

Eligibility

Faculty

Category

Medical
Medical - Clinical Science

External Deadline

May 13, 2024